The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both
Open accessAbstract
BACKGROUND: Patent foramen ovale and atrial septal aneurysm have been identified as potential risk factors for stroke, but information about their effect on the risk of recurrent stroke is limited. We studied the risks of recurrent cerebrovascular events associated with these cardiac abnormalities. METHODS: A total of 581 patients (age, 18 to 55 years) who had had an ischemic stroke of unknown origin within the preceding three months were consecutively enrolled at 30 neurology departments. All patients received aspirin (300 mg per day) for secondary prevention. RESULTS: After four years, the risk of recurrent stroke was 2.3 percent (95 percent confidence interval, 0.3 to 4.3 percent) among the patients with patent foramen ovale alone, 15.2 percent (95 percent confidence interval, 1.8 to 28.6 percent) among the patients with both patent foramen ovale and atrial septal aneurysm, and 4.2 percent (95 percent confidence interval, 1.8 to 6.6 percent) among the patients with neither of these cardiac abnormalities. There were no recurrences among the patients with an atrial septal aneurysm alone. The presence of both cardiac abnormalities was a significant predictor of an increased risk of recurrent stroke (hazard ratio for the comparison with the absence of these abnormalities, 4.17; 95 percent confidence interval, 1.47 to 11.84), whereas isolated patent foramen ovale, whether small or large, was not. CONCLUSIONS: Patients with both patent foramen ovale and atrial septal aneurysm who have had a stroke constitute a subgroup at substantial risk for recurrent stroke, and preventive strategies other than aspirin should be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Interobserver agreement for the assessment of handicap in stroke patients
van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988) · Stroke · doi:10.1161/01.str.19.5.604 · Cited by 6,512
Prevalence of Patent Foramen Ovale in Patients with Stroke
Lechat, P., Mas, J. L., Lascault, G., Loron, P., Theard, M., Klimczac, M., Drobinski, G., Thomas, D., & Grosgogeat, Y. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181802 · Cited by 1,657
Self-citationInteratrial septal abnormalities and stroke: A meta-analysis of case-control studies
Overell, J. R., Bone, I., & Lees, K. R. (2000) · Neurology · doi:10.1212/wnl.55.8.1172 · Cited by 936
PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS
Webster, M. W. I., Smith, H. J., Sharpe, D. N., Chancellor, A. M., Swift, D. L., Bass, N. M., & Glasgow, G. L. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92944-3 · Cited by 823
Patent Foramen Ovale as a Risk Factor for Cryptogenic Stroke
Di Tullio, M., Sacco, R. L., Gopal, A., Mohr, J. P., & Homma, S. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-6-461 · Cited by 600
Cabanes, L., Mas, J. L., Cohen, A., Amarenco, P., Cabanes, P. A., Oubary, P., Chedru, F., Guérin, F., Bousser, M. G., & de Recondo, J. (1993) · Stroke · doi:10.1161/01.str.24.12.1865 · Cited by 572
Self-citationTranscatheter closure of patent foramen ovale after presumed paradoxical embolism.
Bridges, N. D., Hellenbrand, W. E., Latson, L., Filiano, J. J., Newburger, J. W., & Lock, J. E. (1992) · Circulation · doi:10.1161/01.cir.86.6.1902 · Cited by 473
Stroke recurrence in patients with patent foramen ovale: The Lausanne Study
Bogousslavsky, J., Garazi, S., Jeanrenaud, X., Aebischer, N., & Van Melle, G. (1996) · Neurology · doi:10.1212/wnl.46.5.1301 · Cited by 416
Cited by
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Holmes, D. R., Reddy, V. Y., Turi, Z. G., Doshi, S. K., Sievert, H., Buchbinder, M., Mullin, C. M., & Sick, P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61343-x · Cited by 2,240
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Embolic strokes of undetermined source: the case for a new clinical construct
Hart, R. G., Diener, H.-C., Coutts, S. B., Easton, J. D., Granger, C. B., O'Donnell, M. J., Sacco, R. L., & Connolly, S. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70310-7 · Cited by 1,681
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I., Kernan, W. N., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492
Hahn, R. T., Abraham, T., Adams, M. S., Bruce, C. J., Glas, K. E., Lang, R. M., Reeves, S. T., Shanewise, J. S., Siu, S. C., Stewart, W., et al. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.07.009 · Cited by 1,351
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Mas, J.-L., Derumeaux, G., Guillon, B., Massardier, E., Hosseini, H., Mechtouff, L., Arquizan, C., Béjot, Y., Vuillier, F., Detante, O., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1705915 · Cited by 1,183
Self-citationPatent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke
Søndergaard, L., Kasner, S. E., Rhodes, J. F., Andersen, G., Iversen, H. K., Nielsen-Kudsk, J. E., Settergren, M., Sjöstrand, C., Roine, R. O., Hildick-Smith, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707404 · Cited by 1,137
Campbell, B. C. V., & Khatri, P. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31179-x · Cited by 1,116
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Furlan, A. J., Reisman, M., Massaro, J., Mauri, L., Adams, H., Albers, G. W., Felberg, R., Herrmann, H., Kar, S., Landzberg, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1009639 · Cited by 1,060
Homma, S., Sacco, R. L., Di Tullio, M. R., Sciacca, R. R., & Mohr, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000017498.88393.44 · Cited by 949
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Hirsh, J., Fuster, V., Ansell, J., & Halperin, J. L. (2003) · Circulation · doi:10.1161/01.cir.0000063575.17904.4e · Cited by 911
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke
Kent, D. M., Ruthazer, R., Weimar, C., Mas, J.-L., Serena, J., Homma, S., Di Angelantonio, E., Di Tullio, M. R., Lutz, J. S., Elkind, M. S. V., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182a08d59 · Cited by 637
Self-citationEuropean Stroke Initiative Recommendations for Stroke Management – Update 2003
(2003) · Cerebrovascular Diseases · doi:10.1159/000072554 · Cited by 635
Antithrombotic and Thrombolytic Therapy for Valvular Disease
Whitlock, R. P., Sun, J. C., Fremes, S. E., Rubens, F. D., & Teoh, K. H. (2012) · Chest · doi:10.1378/chest.11-2305 · Cited by 625
Patent Foramen Ovale and Cryptogenic Stroke in Older Patients
Handke, M., Harloff, A., Olschewski, M., Hetzel, A., & Geibel, A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071422 · Cited by 613
Dowson, A., Mullen, M. J., Peatfield, R., Muir, K., Khan, A. A., Wells, C., Lipscombe, S. L., Rees, T., De Giovanni, J. V., Morrison, W. L., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.727271 · Cited by 597
Cryptogenic Stroke and High-Risk Patent Foramen Ovale
Lee, P. H., Song, J.-K., Kim, J. S., Heo, R., Lee, S., Kim, D.-H., Song, J.-M., Kang, D.-H., Kwon, S. U., Kang, D.-W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.046 · Cited by 588
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Circulation · doi:10.1161/circ.113.10.e409 · Cited by 541
Management of Grown Up Congenital Heart Disease
Deanfield, J. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00131-3 · Cited by 513
Lamy, C., Giannesini, C., Zuber, M., Arquizan, C., Meder, J. F., Trystram, D., Coste, J., & Mas, J. L. (2002) · Stroke · doi:10.1161/hs0302.104543 · Cited by 509
Self-citationAntithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2004) · Chest · doi:10.1378/chest.126.3_suppl.483s · Cited by 466
Patent Foramen Ovale and Stroke
Homma, S., & Sacco, R. L. (2005) · Circulation · doi:10.1161/circulationaha.104.524371 · Cited by 435
Patent Foramen Ovale: Innocent or Guilty?
Meissner, I., Khandheria, B. K., Heit, J. A., Petty, G. W., Sheps, S. G., Schwartz, G. L., Whisnant, J. P., Wiebers, D. O., Covalt, J. L., Petterson, T. M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.044 · Cited by 430
Khairy, P., O'Donnell, C. P., & Landzberg, M. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-9-200311040-00010 · Cited by 388
Hankey, G. J. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70255-2 · Cited by 384
Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic?
Alsheikh-Ali, A. A., Thaler, D. E., & Kent, D. M. (2009) · Stroke · doi:10.1161/strokeaha.109.547828 · Cited by 378
Patent Foramen Ovale: Current Pathology, Pathophysiology, and Clinical Status
Hara, H., Virmani, R., Ladich, E., Mackey-Bojack, S., Titus, J., Reisman, M., Gray, W., Nakamura, M., Mooney, M., Poulose, A., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.038 · Cited by 345
Cardioembolic stroke: an update
Ferro, J. M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00324-7 · Cited by 332
Patent Foramen Ovale and the Risk of Ischemic Stroke in a Multiethnic Population
Di Tullio, M. R., Sacco, R. L., Sciacca, R. R., Jin, Z., & Homma, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.063 · Cited by 328
Windecker, S., Wahl, A., Nedeltchev, K., Arnold, M., Schwerzmann, M., Seiler, C., Mattle, H. P., & Meier, B. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.044 · Cited by 326
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Albers, G. W., Amarenco, P., Easton, J. D., Sacco, R. L., & Teal, P. (2008) · Chest · doi:10.1378/chest.08-0720 · Cited by 320
Hirsh, J., Fuster, V., Ansell, J., & Halperin, J. L. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00416-9 · Cited by 306
Pepi, M., Evangelista, A., Nihoyannopoulos, P., Flachskampf, F. A., Athanassopoulos, G., Colonna, P., Habib, G., Ringelstein, E. B., Sicari, R., Zamorano, J. L., et al. (2010) · European Journal of Echocardiography · doi:10.1093/ejechocard/jeq045 · Cited by 298
Aetiological diagnosis of ischaemic stroke in young adults
Ferro, J. M., Massaro, A. R., & Mas, J.-L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70251-9 · Cited by 277
Self-citationSaver, J. L. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503946 · Cited by 276
Early and late seizures after cryptogenic ischemic stroke in young adults
Lamy, C., Domigo, V., Semah, F., Arquizan, C., Trystram, D., Coste, J., & Mas, J. L. (2003) · Neurology · doi:10.1212/wnl.60.3.400 · Cited by 275
Self-citationContemporary Management of Patent Foramen Ovale
Meier, B., & Lock, J. E. (2003) · Circulation · doi:10.1161/01.cir.0000046073.34261.c1 · Cited by 256
Amyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older people
Bennett, D. A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054445 · Cited by 99
Metadata
- Authors
- Mas, J.-L., Arquizan, C., Lamy, C., Zuber, M., Cabanes, L., Derumeaux, G., & Coste, J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-12-13
- Volume
- 345
- Issue
- 24
- Pages
- 1740-1746
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2021556603
- Cited by
- 1,361
- References
- 20
- FWCI
- 48.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.